Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹1,047 Cr₹-1,502 Cr₹297 Cr₹942 Cr₹970 Cr

What is the latest Consolidated Net Profit of GLENMARK PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLENMARK PHARMACEUTICALS is ₹1,047 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹1,047 Cr
Mar2025₹-1,502 Cr
Mar2024₹297 Cr
Mar2023₹942 Cr
Mar2022₹970 Cr

How is Consolidated Net Profit of GLENMARK PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹1,047 Cr
Positive
Mar2025 ₹-1,502 Cr
Negative
Mar2024 ₹297 Cr
-68.44
Mar2023 ₹942 Cr
-2.92
Mar2022 ₹970 Cr -

Compare Consolidated Net Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹68,204.9 Cr -1.8% 5.4% 17.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.8%

5.4%

17.8%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses